Rilzabrutinib shows promise in phase-I/II clinical trial for blood disorder IANS Apr 18, 2022 The findings, published in the 'New England Journal of Medicine,' has shown that cells called macrophages are primarily…
Sanofi provides update on phase-III study evaluating Rilzabrutinib to treat pemphigus EP News Bureau Sep 10, 2021 Rilzabrutinib’s safety profile remained consistent with previous results and no new safety signals were identified
